The main points of criticism by Faust et al. (2009) concerning the work in de Figueiredo et al. (2009a) are the following: the cases presented are biased; different tools should be supplied with the same input networks; the number of study cases should be representative; and tools should be evaluated by neutral assessors.
We think that the models in de Figueiredo et al. (2009a) illustrate concrete biological problems that are very well documented. In particular, the conversion of fatty acids into sugars was not so trivial to be answered and is historically relevant (cf. Weinman et al., 1957) . Today, many biochemistry textbooks dedicate at least one paragraph explaining why there is no net conversion of acetyl-CoA to glucose via the tricarboxylic acid cycle in vertebrates (cf. Nelson and Cox, 2000; Stryer, 1995; Voet and Voet, 2004) . Thus, new tools for metabolic pathway prediction have to be able to answer these problems correctly.
Analysing the same network used in (de Figueiredo et al., 2009a) by Path Finding (Croes et al., 2006) , paths converting acetyl-CoA into glucose are computed, even though this is impossible for humans in the network studied. Thus, the critique of Faust et al. (2009) does not bring anything new to what was discussed in de Figueiredo et al. (2009a) .
It is often said that the size of the input network limits the computation of elementary flux modes (EFMs; Faust et al., 2009; Papin et al., 2003 Papin et al., , 2004 . Indeed, the enumeration of all EFMs in genome-scale models with the existing methods is difficult (Klamt et al., 2007; Schwarz et al., 2005; Terzer and Stelling, 2008; von Kamp and Schuster, 2006) . However, there are approaches to compute at least a subset of EFMs in such models (Acuña et al., 2009; de Figueiredo et al., 2009b; Kaleta et al., 2009) , for example, the shortest EFMs (de Figueiredo et al., 2009b) .
Regarding the number of test cases presented in (de Figueiredo et al., 2009a) , we are sure they are representative of the issue that is discussed in that article. More cases exist, for example, the conversion of hypoxanthine into ATP in human erythrocytes, for which EFM analysis can be performed at the cell level (Schuster and Kenanov, 2005) .
Of course, a comparison between tools is preferably made by neutral assessors. However, it is usual in bioinformatics that authors * To whom correspondence should be addressed.
who have established a new tool compare their method with others (Klamt et al., 2007; Urbanczik and Wagner, 2005; Wagner and Urbanczik, 2005) . In addition, one co-author (C.K.) has written an article where EFMs are compared with chemical organizations (Kaleta et al., 2006) .
In the letter by Faust et al. (2009) , it is argued that an incorrect definition of internal metabolites in EFM analysis, can generate wrong pathway predictions. The study of any biochemical system requires the definition of the system's boundary (see, e.g. Schilling and Palsson, 1998) . Thus, the definition of internal and external metabolites in EFM analysis is nothing more than the definition of the boundary conditions found in many other modelling methods. Faust et al. (2009) say that the steady-state constraint is not always an appropriate assumption. Although, in some cases, this assumption is not justified, in many other cases, it is. Accordingly, it is used in many approaches such as Metabolic Control and Flux Balance Analyses. Faust et al. (2009) cite the work of Teusink et al. (2000) to support their statement. However, that work shows that the experimental system does reach a steady state. Additionally, we do not think that the study summarized in Table 1 of Faust et al. (2009) is exhaustive enough with respect to EFMs (cf. Trinh et al., 2009 , for a review).
Nevertheless, the communication from Faust et al. (2009) raises an important point concerning the comparison of tools for metabolic pathway prediction. It is suggested to follow a CASP-like protocol to evaluate the methods for metabolic pathway prediction and that this task should be performed by an independent committee.
The validation process of some of the new tools for metabolic pathway prediction has been performed using the pathway information present in metabolic pathway databases (Blum and Kohlbacher, 2008; Croes et al., 2006) . A CASP-like protocol, to be developed, has to take into account the fact that these databases contain errors (Likić, 2006; Poolman et al., 2006) . On the other hand, only very well-documented pathways are stored in these databases. Many pathways are missing due to the lack of information or simply due to the fact that this classification is performed manually. Furthermore, these databases do not contain all the functional modes of a pathway within a metabolic network, e.g. all the five functional modes of the pentose phosphate pathway in conjunction with glycolysis (Schuster et al., 2000; Stryer, 1995) . Moreover, EFM analysis has been successful in predicting relevant, hitherto unknown pathways, for example, the catabolic PEP-glyoxylate cycle in Escherichia coli (Schuster et al., 1999) , which was later found in Pathway analysis tools experiment (Fischer and Sauer, 2003) and that, to our knowledge, is not present in KEGG nor in MetaCyc (Caspi et al., 2008; Kanehisa et al., 2008) . In conclusion, it is a challenge to represent the combinatorial multitude of biochemical pathways in metabolic databases (Sauer, 2006) . 
